Science Explorer Interactive view Map
University · Utrecht · Netherlands

Medicines Evaluation Board

In research, Medicines Evaluation Board stands highest in Health Sciences (#9,238 of 20,462 worldwide), over all time.

english.cbg-meb.nlROR OpenAlex
World rank, all time
#14,607
of 42,892
Rank in Netherlands
#180
of 464
Research works
309
▼ 13% vs 2013–17
Citations
8.2k
26.6 per fractional work
Top-10% rate
33.3%
record average 16.5%
Open access
53%
world 28%

What is Medicines Evaluation Board known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
Health SciencesDomain #9,238 of 20,462 29.4%133

Each strip is that field’s whole ranked pool, with the notch where Medicines Evaluation Board sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.93× its world share, 2 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.26× its world share, 7 worksBiochemistry, Geneti…Immunology and Microbiology: 5.35× its world share, 3 worksImmunology and Micro…Neuroscience: 0.90× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 17.35× its world share, 4 worksPharmacology, Toxico…Chemical Engineering: 0.63× its world share, 0 worksChemical EngineeringChemistry: 0.32× its world share, 0 worksChemistryComputer Science: 0.12× its world share, 0 worksComputer ScienceEarth and Planetary Sciences: 0.41× its world share, 0 worksEarth and Planetary …Engineering: 0.21× its world share, 2 worksEngineeringEnvironmental Science: 0.45× its world share, 1 worksEnvironmental ScienceMaterials Science: 0.25× its world share, 0 worksMaterials ScienceMathematics: 2.68× its world share, 2 worksMathematicsDentistry: 0.05× its world share, 0 worksDentistryHealth Professions: 0.81× its world share, 1 worksHealth ProfessionsMedicine: 1.82× its world share, 20 worksMedicineNursing: 0.36× its world share, 0 worksNursingVeterinary: 11.19× its world share, 1 worksVeterinaryArts and Humanities: 0.09× its world share, 0 worksArts and HumanitiesDecision Sciences: 1.83× its world share, 1 worksDecision SciencesEconomics, Econometrics and Finance: 5.13× its world share, 6 worksEconomics, Econometr…Psychology: 1.33× its world share, 2 worksPsychologySocial Sciences: 0.24× its world share, 2 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 17.4×. Every wedge is a field page.

Who are the top researchers at Medicines Evaluation Board?

Ranked on the composite score, Sabine M. J. M. Straus lead among researchers whose main affiliation is Medicines Evaluation Board.

  1. 1 Sabine M. J. M. Straus Netherlands · #362,979 worldwide 64 citations · 19 works
All ranked researchers at Medicines Evaluation Board

Which keywords describe research at Medicines Evaluation Board?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Clinical Trials, Adverse Drug Reactions, Cost-effectiveness Analysis, Health Utility Measures, Quality of Life, Regenerative Medicine, Drug Development and Pharmaceutical Industry.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Clinical Trials5▲ 14×11 topics
  2. Adverse Drug Reactions4▲ 129×2 topics
  3. Quality of Life3▲ 4.0×7 topics
  4. Cost-effectiveness Analysis3▲ 60×1 topic
  5. Health Utility Measures3▲ 60×1 topic
  6. Inflammation2▲ 2.1×17 topics
  7. Drug Development2▲ 43×3 topics
  8. Regenerative Medicine2▲ 15×2 topics
  9. Pharmaceutical Industry2▲ 98×2 topics
  10. Biomarkers2▲ 5.1×10 topics
  11. Medication Adherence2▲ 66×2 topics
  12. Pharmacovigilance2▲ 232×1 topic
  13. Signal Detection2▲ 232×1 topic
  14. Off-Label Drug Use2▲ 124×1 topic
  15. Patient Safety2▲ 22×2 topics
  16. Pediatric Pharmacokinetics2▲ 124×1 topic
  17. Regulatory Challenges2▲ 33×2 topics
  18. Direct-to-Consumer Marketing2▲ 120×1 topic
  19. Publication Bias2▲ 61×3 topics
  20. Stem Cell Regulation2▲ 120×1 topic
  21. Drug Development Costs2▲ 99×1 topic
  22. Generic Drugs2▲ 99×1 topic
  23. Bayesian Methods1▲ 48×2 topics
  24. Vaccine1▲ 6.1×5 topics
  25. Adaptive Designs1▲ 109×1 topic
  26. False Discovery Rate1▲ 109×1 topic
  27. Genetic Variants1▲ 13×3 topics
  28. Monoclonal Antibodies1▲ 24×3 topics
  29. Pharmacokinetics1▲ 8.5×4 topics
  30. SARS-CoV-21▲ 7.0×4 topics
  31. Biopharmaceuticals1▲ 40×2 topics
  32. Food Safety1▲ 7.1×3 topics
  33. Immunogenicity1▲ 48×2 topics
  34. Bioanalytical Methods1▲ 96×1 topic
  35. Biosimilars1▲ 96×1 topic
  36. Mutation1▲ 10×2 topics
  37. Mycobacterium tuberculosis1▲ 35×2 topics
  38. ACE2 Receptor1▲ 7.4×2 topics
  39. Coronavirus1▲ 8.4×2 topics
  40. Method Validation1▲ 33×2 topics

Which research topics does Medicines Evaluation Board publish most on?

By volume in 2022–2025: Health Systems, Economic Evaluations, Quality of Life, Pharmacovigilance and Adverse Drug Reactions, Pharmaceutical studies and practices and Biomedical Ethics and Regulation.

Health Systems, Economic Evaluations, Quality of Life: 3 fractional worksPharmacovigilance and Adverse Drug Reactions: 2 fractional worksPharmaceutical studies a…2Pharmaceutical studies and practices: 2 fractional worksBiomedical Ethics and Re…2Biomedical Ethics and Regulation: 2 fractional worksPharmaceutical Economics and Policy: 2 fractional worksStatistical Methods in Clinical Trials: 1 fractional worksBiosimilars and Bioanaly…1Biosimilars and Bioanalytical Methods: 1 fractional worksSteroid Chemistry and Biochemistry: 1 fractional worksPesticide Residue Analysis and Safety: 1 fractional worksEuropean Monetary and Fiscal Policies: 1 fractional works
Economics and EconometricsToxicologyPediatrics, Perinatology and Child HealthPhysiology5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 3 works
  2. 2 Pharmacovigilance and Adverse Drug Reactions Toxicology 2 works
  3. 3 Pharmaceutical studies and practices Pediatrics, Perinatology and Child Health 2 works
  4. 4 Biomedical Ethics and Regulation Physiology 2 works
  5. 5 Pharmaceutical Economics and Policy Economics and Econometrics 2 works
  6. 6 Statistical Methods in Clinical Trials Statistics and Probability 1 works
  7. 7 Biosimilars and Bioanalytical Methods Immunology 1 works
  8. 8 Steroid Chemistry and Biochemistry Molecular Biology 1 works
  9. 9 Pesticide Residue Analysis and Safety Food Science 1 works
  10. 10 European Monetary and Fiscal Policies Finance 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available52.9%not open47.1%

World: 28% of research is openly available.

with international co-authors32.7%domestic only67.3%

World: 19% is written across borders.

How has Medicines Evaluation Board's research output changed?

Output in 2018–2022 was 13% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Utrecht

All research institutions in Utrecht

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.